Genfit Competitors and Similar CompaniesClear all
Genfit's competitors and similar companies include Ablynx.
 Genfit GENFIT is a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions to address high unmet patient needs. |  Ablynx Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments. | |
Founding Date | Founding Date 1999 | Founding Date 2001 |
Type | Type Public | Type Subsidiary |
Tags | ||
Locations | Locations Loos, FR HQ Cambridge, US | Locations Gent, BE HQ |
Employees | Employees 180 | Employees 1252% decrease |
Financial | ||
Revenue (est.) | Revenue (est.) €65.4m (FY, 2025) | Revenue (est.) €85.2m (FY, 2016) |
Net income | Net income (€86m) (FY, 2025) | Net income (€1.1m) (FY, 2016) |
Operating ⚠ | ||
Patents (Foreign) | Patents (Foreign) 450 (FY, 2019) | Patents (Foreign) 180 (Q2, 2017) |
Patents (US) | Patents (US) 28 (FY, 2019) | Patents (US) 50 (Q2, 2017) |
For sources of this data, please see the company profile
View Company Profiles
Ablynx
HQ
Gent, BE
Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments.
View company